Centenarian controls increase variant effect sizes by an average twofold in an extreme case–extreme control analysis of Alzheimer’s disease
Niccoló Tesi(Amsterdam UMC Location University of Amsterdam), Henne Holstege(Amsterdam University Medical Centers), Martijn Huisman(GGD Amsterdam), Wiesje M. van der Flier(Amsterdam Neuroscience), Najada Stringa(Amsterdam University Medical Centers), Natasja M. van Schoor(Amsterdam University Medical Centers), Marc Hulsman(Amsterdam University Medical Centers), Marcel Reinders(Leiden University), Sven J. van der Lee(Amsterdam Neuroscience), Hanne Meijers‐Heijboer(German Cancer Research Center), Iris E. Jansen(Amsterdam Neuroscience), Philip Scheltens(Amsterdam University Medical Centers)
Cited by 64
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
|Nature Genetics|2019|3.3k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k